Armata Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $966 | $1,528 |
Gross Profit | -315 | 649 | 1,235 | |
EBITDA | -2,245 | 12,019 | -22,884 | -18,104 |
EBIT | -2,558 | 11,704 | -23,201 | -18,397 |
Net Income | -5,481 | 8,986 | -25,021 | -19,847 |
Net Change In Cash | 0 | 0 | 966 | 1,528 |
Free Cash Flow | -9,203 | -11,543 | -10,834 | -10,506 |
Cash | 17,141 | 26,405 | 37,860 | 13,523 |
Basic Shares | 36,180 | 58,246 | 36,124 | 36,100 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $4,529 | $5,508 | $4,474 | $823 |
Gross Profit | -29,241 | 4,616 | -15,541 | -13,621 |
EBITDA | -39,918 | -36,054 | -22,653 | -20,439 |
EBIT | -40,890 | -36,946 | -23,822 | -21,553 |
Net Income | -69,045 | -36,888 | -23,219 | -22,815 |
Net Change In Cash | 4,529 | 5,508 | 4,474 | 823 |
Cost of Revenue | 9,324 | 639 | 4,116 | |
Free Cash Flow | -55,567 | -34,692 | -24,879 | -19,094 |
Cash | 13,523 | 14,852 | 10,288 | 9,649 |
Basic Shares | 36,075 | 34,294 | 24,104 | 16,415 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.15 |
2024-06-30 | $0.25 |
2024-03-31 | -$0.69 |
2023-12-31 | -$0.55 |
